Please login to the form below

Not currently logged in
Email:
Password:

Emergent BioSolutions

This page shows the latest Emergent BioSolutions news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs over-the-counter use of Emergent BioSolutions’ Narcan

FDA panel backs over-the-counter use of Emergent BioSolutions’ Narcan

The US Food and Drug Administration's (FDA’s) panel of advisors has unanimously voted in favour of an over-the-counter (OTC) version of Emergent BioSolutions’ opioid overdose-reversing drug. ... Paul Williams, senior vice president and products

Latest news

  • Pushing all the wrong buttons Pushing all the wrong buttons

    One need look no further than the aforementioned tragedy at Emergent BioSolutions which resulted in those 15 million Johnson and Johnson doses being tossed in the garbage. ... Apparently, it has been known for well over a year that Emergent BioSolutions

  • J&J halts manufacturing of COVID-19 at US plant after FDA warning J&J halts manufacturing of COVID-19 at US plant after FDA warning

    In a statement, the FDA announced that it recently completed an inspection of a proposed manufacturing site for J&J’s COVID-19 vaccine in Baltimore, operated by Emergent BioSolutions. ... Emergent BioSolutions has now paused new production of the J&J

  • Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

    Follows initial deal agreed in June. US-based CDMO Emergent BioSolutions has agreed a deal with AstraZeneca to expand manufacturing of the latter's potential COVID-19 vaccine. ... According to Emergent, the deal is valued at approximately $174m and runs

  • Shake-up at GSK could claim antibiotics unit and UK facilities Shake-up at GSK could claim antibiotics unit and UK facilities

    In the meantime the company has also announced a product divestment - selling its anthrax prevention drug raxibacumab to Emergent BioSolutions for around $96m. ... The FDA-approved therapy is tied to a $130m supply deal with the US government, which will

  • GSK: We had a social responsibility to work on Ebola GSK: We had a social responsibility to work on Ebola

    More recently it was revealed this week that will be working with Emergent BioSolutions on a phase I trial that would addd that firm's Ebola vaccine candidate as a booster

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch table for August 2014 Deal Watch table for August 2014

    187. Emergent BioSolutions/ Morphosys. Licence, joint development &commercialisation. MOR209/ES414, anti-PSMA/anti-CD3 bi-specific antibody targeting prostate cancer (preclinical).

  • Deal Watch table for April 2013 Deal Watch table for April 2013

    60. Bracco Diagnostics/ Emergent BioSolutions. Asset purchase. Healthcare Protective Products Division.

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    But it doesn't stop the contagious form acquired by adults. So we are working with Emergent BioSolutions and Aeras, a non-profit product developer, as well as institutions in the

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Barry Labinger joins Biothera Pharmaceutical Barry Labinger joins Biothera Pharmaceutical

    Labinger has nearly three decades of pharmaceutical and biotech industry experience, with roles at Emergent BioSolutions, Human Genome Sciences, 3M Pharmaceuticals and Immunex. ... Labinger most recently served as executive vice president and president,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....